China Animal Husbandry Industry Co., Ltd. Class A

China Animal Husbandry Industry Co., Ltd. Class A

SSSE:600195
6.11
CNY
-0.03
(-0.49%)
0.01EPS
1,623.72P/E
6.87BMarket Cap
Apr 09Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
3.91
4
4.19
3.93
4.03
4.39
4.07
4.93
5.22
5.78
5.29
5.89
6.08
6.21
Basic EPS, GAAP
0.25
0.29
0.27
0.33
0.4
0.41
0.25
0.41
0.51
0.54
0.39
0.07
0.17
- -
Free Cash Flow per Basic Share
-0.01
-0.11
0.19
0.43
-0.04
-0.03
-0.43
0.13
-0.09
-0.67
-0.26
-0.04
0.9
- -
Dividend per Share
0.1
0.08
0.1
0.09
0.15
0.19
0.18
0.09
0.13
0.16
0.21
0.16
0.05
0.08
Book Value per Share
2.58
2.83
3.01
3.31
3.64
3.96
4.15
4.41
4.84
5.19
5.41
5.39
5.55
5.55
Tangible Book Value per Share
2.35
2.48
2.59
2.82
3.08
3.33
3.37
3.67
4.1
4.47
4.57
4.6
4.88
4.46
Basic Weighted Avg Shares
932
1,010
1,010
1,010
1,010
1,010
1,016
1,014
1,016
1,018
1,021
1,021
1,021
1,021
Sales/Revenue/Turnover
3,640
4,035
4,234
3,974
4,070
4,434
4,136
4,999
5,302
5,892
5,406
6,017
6,205
6,336
Operating Margin (%)
7.26
5.42
7.07
7.12
6.7
8.02
4.74
7.29
9.76
6.83
4.43
0.89
1.08
2.58
Depreciation Expense
89
139
162
177
180
168
183
188
262
265
297
321
346
- -
Net Income, GAAP
236
290
276
334
400
416
249
420
514
550
403
71
171
4
Effective Tax Rate (%)
16.89
14.64
16.34
15.65
13.95
13.63
16.08
11.71
12.24
12.13
14.63
37.45
19.11
84.38
Profit Margin (%)
6.48
7.19
6.51
8.42
9.83
9.37
6.03
8.41
9.69
9.34
7.46
1.18
2.76
0.07
Working Capital
1,281
1,002
899
2,198
2,385
1,421
1,307
1,551
1,489
1,858
2,382
1,890
1,852
2,016
LT Debt
- -
- -
- -
1,191
1,193
- -
40
85
84
35
901
666
301
1,328
Total Equity
2,858
3,176
3,356
3,676
3,954
4,485
4,773
5,369
5,874
6,342
6,541
6,499
6,560
7,001
Return on Invested Capital (%)
9.72
9.16
8.37
8.46
8.4
8.14
5.04
11.56
10.14
8.63
4.74
0.76
2.82
0.28
Return on Capital (%)
9.09
10.09
8.43
8.15
8.13
7.63
4.3
7.19
7.71
8.81
6.6
1.36
2.51
-0.01
Return on Common Equity (%)
10.38
10.62
9.36
10.48
11.38
10.83
6.09
9.69
10.94
10.78
7.45
1.29
3.07
0.08

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
881
844
709
LT Borrowings
349
267
1,324
LT Finance Leases
5
2
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,021
1,021
1,021
Market Capitalization
7,567
6,025
6,872

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
4,726
4,555
4,597
Cash, Cash Equivalents & STI
1,897
1,851
1,650
Accounts Receivable, Net
999
1,082
1,130
Inventories
1,098
1,095
1,277
Total Current Liabilities
2,733
2,568
2,582
Payables & Accruals
- -
- -
- -
ST Debt
881
844
709
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.02%
4.16%
0.93%
Free Cash Flow
-97.38%
-427.26%
-2,435.6%
Net Income, GAAP
13.52%
12.36%
141.68%
Sales/Revenue/Turnover
4.27%
4.67%
3.11%
Total Cash Common Dividend
3.33%
1.69%
-69.61%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,125
1,354
1,699
1,839
6,017
2025
1,259
1,534
- -
1,762
6,205
2026
1,509
1,662
1,403
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.07
-0.01
0.02
-0.01
0.07
2025
0.06
0.02
- -
-0.05
0.17
2026
0.02
0.03
0.01
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.01
0.13
0.01
0.16
2025
0.01
- -
- -
0.01
0.05
2026
- -
0.01
0.06
- -
- -

Company Description

CEO
Yin Li
Full Time Employees
3,996
Sector
Health technology
Industry
Biotechnology
Address
Building 16-19 Beijing BE China 100070
IPO Date
Jan 7, 1999
Website
cahic.com
Business
China Animal Husbandry Industry Co., Ltd. (600195.SS) engages in the research, development, production, and distribution of animal health products and services in China. The company offers a comprehensive portfolio of veterinary pharmaceuticals, including antibiotics, vaccines, and feed additives; biological products such as poultry and livestock vaccines; nutritional supplements and premixes for animal feed; and diagnostic reagents and testing services for disease prevention and control. It operates primarily in the animal husbandry sector, serving livestock farmers, feed mills, and veterinary clinics across mainland China, with headquarters in Beijing and founded in 1998. In recent developments, the company expanded its product offerings through strategic partnerships with international biotech firms for advanced vaccine technologies in 2024; completed a funding round to support new manufacturing facilities in 2025; and launched innovative recombinant protein-based vaccines for porcine diseases amid rising demand in the swine industry.